Nephrogenic diabetes insipidus

Current Opinion in Pediatrics

Volumn 29, Issue 2, 2017, Pages 199-205

  Bockenhauer, D ^a   Bichet, Daniel G ^b,c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

AQP2; AVPR2; hypernatremic dehydration; MAGED2; nephrogenic diabetes insipidus; thirst; vasopressin V2 receptor bypassing compounds

Indexed keywords

ELECTROLYTE; SODIUM; SODIUM CHLORIDE; VASOPRESSIN V2 RECEPTOR; ARGININE VASOPRESSIN RECEPTOR 2, HUMAN; VASOPRESSIN RECEPTOR;

BARTTER SYNDROME; DEHYDRATION; FEEDING DIFFICULTY; FLUID INTAKE; FOOD AVERSION; GENE MUTATION; HUMAN; HYDRAMNIOS; HYPERNATREMIA; KIDNEY CONCENTRATING CAPACITY; KIDNEY TUBULE ABSORPTION; MOTOR DEVELOPMENT; NEPHROGENIC DIABETES INSIPIDUS; PREMATURITY; REVIEW; SEQUENCE ANALYSIS; URINE OSMOLALITY; VOMITING; WATER DEPRIVATION; CASE REPORT; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; INFANT; MALE; MULTIMODALITY CANCER THERAPY; MUTATION; RARE DISEASE; RISK ASSESSMENT;

COMBINED MODALITY THERAPY; DEHYDRATION; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MUTATION; RARE DISEASES; RECEPTORS, VASOPRESSIN; RISK ASSESSMENT;

EID: 85011000148     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000473     Document Type: Review

References (18)

1. Bockenhauer D, Bichet DG. Pathophysiology diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015; 11:576-588.
2. Laghmani K, Beck BB, Yang SS, et al. Polyhydramnios, transient antenatal Bartters syndrome, andMAGED2 mutations. N Engl J Med 2016; 374:1853-1863.
3. Procino G, Carmosino M, Milano S, et al. Beta-3 adrenergic receptor (b3-AR) in the kidney: A possible new player in sympathetic regulation of renal function. Kidney Int 2016; 90:555-567.
4. Cernecka H, Sand C, Michel MC. The odd sibling: features of beta3-Adrenoceptor pharmacology. Mol Pharmacol 2014; 86:479-484.
5. Lu X, Wang F, Xu C, et al. Soluble (pro)renin receptor via beta-catenin enhances urine concentration capability as a target of liver X receptor. Proc Natl Acad Sci U S A 2016; 113:E1898-E1906.
6. Wang F, Lu X, Peng K, et al. Antidiuretic action of collecting duct (Pro)renin receptor downstream of vasopressin and PGE2 receptor EP4. J Am Soc Nephrol 2016; 27:3022-3034.
7. Klein JD, Wang Y, Blount MA, et al. Metformin an AMPK activator, stimulates the phosphorylation of Aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. Am J Physiol Renal Physiol 2016; 310:F1008-F1012.
8. Cheung PW, Nomura N, Nair AV, et al. EGF receptor inhibition by erlotinib increases Aquaporin 2-mediated renal water reabsorption. J Am Soc Nephrol 2016; 27:3105-3116.
9. Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci 2008; 9:519-531.
10. Bichet DG. beta3-Adrenoreceptors in the thick ascending limb of Henle and in principal cells of the collecting duct work to concentrate urine. Kidney Int 2016; 90:471-473.
11. Oka Y, Ye M, Zuker CS. Thirst driving and suppressing signals encoded by distinct neural populations in the brain. Nature 2015; 520:349-352.
12. Zimmerman CA, LinYC, Leib DE, et al. Thirst neurons anticipate thehomeostatic consequences of eating and drinking. Nature 2016; 537:680-684.
13. Perry TL, Robinson GC, Teasdale JM, Hansen S. Concurrence of cystathioninuria, nephrogenic diabetes insipidus and severe anemia. N Engl J Med 1967; 276:721-725.
14. Bichet DG, Arthus M-F, Lonergan M, et al. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 1993; 92:1262-1268.
15. Sterns RH. Disorders of plasma sodium: causes, consequences, and correction. N Engl J Med 2015; 372:55-65.
16. Arthus M-F, Lonergan M, Crumley MJ, et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 2000; 11:1044-1054.
17. Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 2002; 112:183-190.
18. Marek S, Tekesin I, Hellmeyer L, et al. Differential diagnosis of a polyhydramnion in hyperprostaglandin E syndrome: A case report. Z Geburtshilfe Neonatol 2004; 208:232-235.